ENO2 and carcinoma: According to the current WHO they are defined as carcinomas exhibiting expression of synaptophysin and/or chromogranin A with the exception of small cell carcinoma which is defined morphologically and usually only exhibits limited or less frequent expression of specific neuroendocrine markers but expresses NSE more frequently [3].